by Devices and Pharma | Apr 18, 2024 | FDA Approvals, Industry News, Med-Devices, New devices, Product-Innovation
Biotronic NRO's Prospera Spinal Cord Stimulation System Intended to treat for chronic, intractable back pain Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact...
by Devices and Pharma | Apr 18, 2024 | FDA Public Information, FDA Reports, Industry News, Med-Devices, Product-Innovation, US-FDA
CDRH Issues its 2024 Innovation Report Commitment to medical device innovation and safety Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact Revolutionizing Medical...
by Devices and Pharma | Apr 18, 2024 | FDA Reports, Industry News, Med-Devices, Product Safety, US-FDA
CDRH Issues its 2024 Safety Report Commitment to safety and effectiveness of medical devices Home About Consumer Medical Devices Pharma Biologics Biologics Warning Letters AI Regulatory Quality QMSR Central News Enforcement Alerts Innovation Contact 2024 CDRH Safety...
by Devices and Pharma | Apr 3, 2024 | FDA Approvals, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA
FDA Approves New Antibiotic for Three Different Uses Zevtera effective against three bacterial infections Home About Consumer News Food and Beverage Supplements Cosmetics Regulatory Medical Devices Pharma Biologics Combination Products In Vitro Diagnostics Veterinary...
by Devices and Pharma | Mar 31, 2024 | Alerts-Pharma, Consumer Safety, FDA Public Information, FDA Safety Communication, Industry News, Product Safety, US-FDA
FDA Warns of Risks with OTC Pain Relief Products High lidocaine concentrations, other issues Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact The U.S. Food and Drug...
by Devices and Pharma | Mar 31, 2024 | FDA Approvals, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA
New Treatment for Platinum-Resistant Ovarian Cancer Mirvetuximab Soravtansine-Gynx (Elahere) Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact In a significant...
